Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mG9v2jAQxt/zKaK8J6GUjnQKVBtrN6RWY7Ro094gkxzFzLXTs8Offfo5hGrp5Kytwe8gTp67+B7/7pT4YvPAvBWgpIL3/JOg5XvAE5FSft/zJ3dXzci/6DfiJVmRym3doBWctH0vYUTKnl+sBjMgXAY/bq4/gX4e0O83vFjMlpCoZ/flirLgC5GLG5IV93jxStDUewC1EGnPz3K1u+rFUqHOor8W+EtmJIE43F+pri6nner1OCzEXqGaS8Brwu+NonO00kxyROBqQBTcC9yapZNpO+q+a7UiqxBUjkGKHBMYEbUYoVjRFFJzJMIkWAWZr9NbwBUDVQQxiofL5EFaiZMl2YzhcWhO+oNeHaiNaraaJ92zTjs6Oz0/63btNgsrW2U2j36JMMswnbbPdaSoG84xTFEwyBThTf0rA6SpYJa1GglUhDmqEpWD535zFAfh8UU3pFRmjGyDpcxst4og0cuAmgruXqR4gzvUnGJ6z/7R5zlj4Ruznuwp4ijjAlIDkXNVA5Orse1GDARXsKmvqB3/1GbvRQryeLK/BTezf5TPGE1sEachlINUk/GwnnAu4fCRSJigOzp8pzwVa3l86lSr7Cj7bAfO/zTQThRF1kfqpzZUTf+5zIuyhppGVB4CmSGfi0Pxoj1qlnpyqDNz7oYjkRAGNeNR05I82pVP05wz37s7U+WCUfTz5Z2tXb7lgNvb3V+jNE171ULbkdkF7rU/a3N/u9vLI/+K2bkTnbbtXI1moiyUyuT7MFyv18GCyKYkerMCfZ5cd4BKE3Y3yTvp9OXkU3LUUeqzsj2+rWK2Z/ClWeDQ+Xb//H6ONsZQmMMBtShx7Qyqw8vjc/rvcOss7dEzqLgLsxtEiaKCuxqI8plR8eDOoEvLr1Az4ut8Tmu+sdRaMw7L7zv9RhwW33b6jT8N+wS0
2HvFSBqkAYbk87Dz